FDA Monthly Preview: Key May Decisions to Watch
-
By
-
Kathryn Wighton
-
April 29, 2026
-
4 min
By
Kathryn Wighton
April 29, 2026
A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.
July 31, 2026
Lower cognition is associated with later depression in controls, while higher cognition is associated with relapse in remitted depression
June 1, 2026
Findings support greater attention to stroke prevention and poststroke cognitive monitoring.
June 5, 2026